Evaluación del tratamiento de la fibrilación auricular valvular y no valvular y su relación con eventos adversos en pacientes hospitalizados en el servicio de urgencias de un hospital de tercer nivel

Wolf, 1991, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke., 22, 983, 10.1161/01.STR.22.8.983 Kirchhof, 2016, ESC Guidelines for the management of atrial fibrillation developed in colla*boration with EACTS, Eur J Cardiothorac Surg. 2016, 10.1093/ejcts/ezw313 Roselli, 2013, Prevalencia de fibrilación auricular en un hospital universitario colombiano, Rev Col Cardiol., 20, 383 Chugh, 2014, Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study, Circulation., 837, 10.1161/CIRCULATIONAHA.113.005119 Benjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation;, 98, 946, 10.1161/01.CIR.98.10.946 Bjorck, 2013, Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study, Stroke, 44, 3103, 10.1161/STROKEAHA.113.002329 Haim, 2015, Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation, J Am Heart Assoc, 4, e001486, 10.1161/JAHA.114.001486 Wattigney, 2003, Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention, Circulation., 108, 711, 10.1161/01.CIR.0000083722.42033.0A Gladstone, 2009, Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated, Stroke., 40, 235, 10.1161/STROKEAHA.108.516344 Gattellari, 2011, Outcomes for patients with ischaemic stroke and atrial fibrillation: the PRISM study (A Program of Research Informing Stroke Management), Cerebrovasc Dis., 32, 370, 10.1159/000330637 Gorin, 2011, Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project.Chest., 140, 911 Pinto, 2016, Descripción de los pacientes con fibrilación auricular no valvular que ingresan al servicio de urgencias, Rev Colomb Cardiol., 23, 270 Szymanski, 2015, Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of «High Stroke Risk» Patients With Atrial Fibrillation, Am J Cardiol, 10.1016/j.amjcard.2015.08.049 Keogh, 2011, Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke. A systematic review and meta-analysis, ThrombHaemost, 106, 528e538 Karthikeyan, 2010, The CHADS2 score for stroke risk stratification in atrial fibrillation—friend or foe?, ThrombHaemost, 104, 45e48 Pisters, 2010, A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation, Chest., 138, 1093, 10.1378/chest.10-0134 Raffaele De Caterinaand, 2014, What is ‘valvular’ atrial fibrillation?. A reappraisal, Eur Heart J., 35, 3328, 10.1093/eurheartj/ehu352 Ortega, 2016, ¿Están correctamente anticoagulados nuestros pacientes con fibrilación auricular no valvular?, Rev Colomb Cardiol., 23, 361 Oldgren J, et al. RE-LY Atrial Fibrillation Registry Investigators. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry. Circulation. 2014; 129(15):1568-76. January CT, et al. ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014; 130(23):2071-104. Quinn RR, et al. Canadian Hypertension Education Program. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol. 2010; 26(5):241-8. O’Reilly, 2013, The burden of atrial fibrillation on the hospital sector in Canada, Can J Cardiol., 29, 229, 10.1016/j.cjca.2012.03.023 Han, 2018, Anticoagulation therapy in patients with stroke and atrial fibrillation: a registry-based study of acute stroke care in Surrey, UK. BMJ Open., 8, e022558, 10.1136/bmjopen-2018-022558 Lamassa, 2001, Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project), Stroke., 32, 392, 10.1161/01.STR.32.2.392 Benjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation., 98, 946, 10.1161/01.CIR.98.10.946 Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med., 146, 857, 10.7326/0003-4819-146-12-200706190-00007 Connolly SJ, et al. RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361(12):1139-51. Flaker, 2014, ARISTOTLE Committees and Investigators Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial, J Am Coll Cardiol., 64, 1541, 10.1016/j.jacc.2014.07.967 Kirchhof, 2009, Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference’research perspectives in AF’, Eur Heart J., 30, 2969, 10.1093/eurheartj/ehp235 Penttilä, 2017, FinFib2 investigators Antiarrhythmic drug therapy among patients presenting to emergency department with symptomatic atrial fibrillation - a prospective nationwide cohort, Scand J Trauma Resusc Emerg Med., 25, 81, 10.1186/s13049-017-0424-7 Stiell, 2017, Outcomes for emergency department patients with recent-onset atrial fibrillation and flutter treated in canadian hospitals, Ann Emerg Med., 69, 562, 10.1016/j.annemergmed.2016.10.013 Barbic, 2018, Implementation of an emergency department atrial fibrillation and flutter pathway improves rates of appropriate anticoagulation, reduces length of stay and thirty-day revisit rates for congestive heart failure, CJEM., 20, 392, 10.1017/cem.2017.418